NNovo Nordisk Read More Novo Nordisk Faces a Fork in the Road as Pipeline Progress Meets Profit Pressure2026-04-28 Novo Nordisk stock trades 50% below peak amid GLP-1 competition from Eli Lilly’s oral pill, regulatory wins, and…